These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24675149)

  • 1. Modulation of methamphetamine's locomotor stimulation and self-administration by JHW 007, an atypical dopamine reuptake blocker.
    Ferragud A; Velázquez-Sánchez C; Canales JJ
    Eur J Pharmacol; 2014 May; 731():73-9. PubMed ID: 24675149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The high affinity dopamine uptake inhibitor, JHW 007, blocks cocaine-induced reward, locomotor stimulation and sensitization.
    Velázquez-Sánchez C; Ferragud A; Murga J; Cardá M; Canales JJ
    Eur Neuropsychopharmacol; 2010 Jul; 20(7):501-8. PubMed ID: 20413276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors.
    Hiranita T; Soto PL; Newman AH; Katz JL
    J Pharmacol Exp Ther; 2009 May; 329(2):677-86. PubMed ID: 19228996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement treatment during extinction training with the atypical dopamine uptake inhibitor, JHW-007, reduces relapse to methamphetamine seeking.
    Dassanayake AF; Canales JJ
    Neurosci Lett; 2018 Apr; 671():88-92. PubMed ID: 29452175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Place conditioning and locomotor effects of N-substituted, 4',4''-difluorobenztropine analogs in rats.
    Li SM; Newman AH; Katz JL
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1223-30. PubMed ID: 15743929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dopamine uptake inhibitor 3 alpha-[bis(4'-fluorophenyl)metoxy]-tropane reduces cocaine-induced early-gene expression, locomotor activity, and conditioned reward.
    Velázquez-Sánchez C; Ferragud A; Hernández-Rabaza V; Nácher A; Merino V; Cardá M; Murga J; Canales JJ
    Neuropsychopharmacology; 2009 Nov; 34(12):2497-507. PubMed ID: 19606084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The atypical dopamine transport inhibitor, JHW 007, prevents amphetamine-induced sensitization and synaptic reorganization within the nucleus accumbens.
    Velázquez-Sánchez C; García-Verdugo JM; Murga J; Canales JJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jul; 44():73-80. PubMed ID: 23385166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic-like properties of a dopamine uptake inhibitor in animal models of amphetamine addiction.
    Velazquez-Sanchez C; Ferragud A; Renau-Piqueras J; Canales JJ
    Int J Neuropsychopharmacol; 2011 Jun; 14(5):655-65. PubMed ID: 20735880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral and neurochemical effects of the dopamine transporter ligand 4-chlorobenztropine alone and in combination with cocaine in vivo.
    Tolliver BK; Newman AH; Katz JL; Ho LB; Fox LM; Hsu K; Berger SP
    J Pharmacol Exp Ther; 1999 Apr; 289(1):110-22. PubMed ID: 10086994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dopamine transport inhibitor with markedly low abuse liability suppresses cocaine self-administration in the rat.
    Ferragud A; Velázquez-Sánchez C; Hernández-Rabaza V; Nácher A; Merino V; Cardá M; Murga J; Canales JJ
    Psychopharmacology (Berl); 2009 Dec; 207(2):281-9. PubMed ID: 19756525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The stereotypy-inducing effects of N-substituted benztropine analogs alone and in combination with cocaine do not account for their blockade of cocaine self-administration.
    Li L; Hiranita T; Hayashi S; Newman AH; Katz JL
    Psychopharmacology (Berl); 2013 Feb; 225(3):733-42. PubMed ID: 22975727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3'- and 4'-chloro-substituted analogs of benztropine: intravenous self-administration and in vitro radioligand binding studies in rhesus monkeys.
    Woolverton WL; Rowlett JK; Wilcox KM; Paul IA; Kline RH; Newman AH; Katz JL
    Psychopharmacology (Berl); 2000 Jan; 147(4):426-35. PubMed ID: 10672637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-{2-[bis-(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine], and benztropine analogs.
    Desai RI; Kopajtic TA; French D; Newman AH; Katz JL
    J Pharmacol Exp Ther; 2005 Oct; 315(1):397-404. PubMed ID: 16014753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands.
    Katz JL; Kopajtic TA; Agoston GE; Newman AH
    J Pharmacol Exp Ther; 2004 May; 309(2):650-60. PubMed ID: 14755006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical efficacy of N-substituted benztropine analogs as antagonists of methamphetamine self-administration in rats.
    Hiranita T; Kohut SJ; Soto PL; Tanda G; Kopajtic TA; Katz JL
    J Pharmacol Exp Ther; 2014 Jan; 348(1):174-91. PubMed ID: 24194527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 4'-chloro-3 alpha-(diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: comparison with effects of cocaine.
    Tanda G; Ebbs A; Newman AH; Katz JL
    J Pharmacol Exp Ther; 2005 May; 313(2):613-20. PubMed ID: 15681658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further delineation between typical and atypical dopamine uptake inhibitors: effects on food-maintained behavior and food consumption.
    Slezak JM; Desai RI; Katz JL
    Behav Pharmacol; 2017 Feb; 28(1):74-82. PubMed ID: 27926573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
    Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
    J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further studies of the reinforcing effects of benztropine analogs in rhesus monkeys.
    Woolverton WL; Hecht GS; Agoston GE; Katz JL; Newman AH
    Psychopharmacology (Berl); 2001 Apr; 154(4):375-82. PubMed ID: 11349390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applicability of the dopamine and rate hypotheses in explaining the differences in behavioral pharmacology of the chloro-benztropine analogs: studies conducted using intracerebral microdialysis and population pharmacodynamic modeling.
    Othman AA; Newman AH; Eddington ND
    J Pharmacol Exp Ther; 2007 Aug; 322(2):760-9. PubMed ID: 17519385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.